Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters et al. · CHEST Journal · 2009 · 6.7K citations · Full text

Medicine, Cardiology, Clinical Sciences +16

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

A. John Camm, Gregory Y.H. Lip, Raffaele De Caterina et al. · European Heart Journal · 2012 · 2.9K citations · Full text

Medicine, Cardiology, Internal Medicine +17